ANAMORF financials
A multi-period view of the public annual-account figures reported for ANAMORF, with comparable measures and links to available source documents.
Company overviewRegistry number
0895284066
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for ANAMORF
2025 versus 2024
- Operating line
- €38,683
- EBITDA
- €36,775
- Total assets
- €325,667
- Equity
- €93,286
-19.5%
-20.3%
-7%
+3.4%
EBITDA margin +95.1% · Equity ratio +28.6%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €38,683 | €36,775 | €325,667 | €93,286 | - |
| 202431 Dec 2024 | €48,033 | €46,121 | €350,149 | €90,191 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.